Upcoming IPOs
Dr. Soliman Abdel Kader Fakeeh Hospital Company ("Fakeeh Care Group") (Ticker: TBA) is a healthcare company that owns, operates, and manages hospitals, clinics, and other healthcare facilities. The company also manages medical education and training centers, laboratories, radiology centers, and pharmacies. Fakeeh Care Group is expected to list on May 21, 2024, on the Main Market of the Saudi Exchange. The firm is offering 30 million new shares and 19.8 million secondary shares from selling shareholders at the price of SAR 57.50 per share. The expected total offer size is SAR 2.86 billion (USD 763 million). The offering represents 21.47% of the company's share capital post-capital increase. HSBC Saudi Arabia is acting as the Sole Financial Advisor, Joint Bookrunner, Underwriter, and Lead Manager for the IPO.
Go Digit General Insurance Ltd (Ticker: TBA) is a property and casualty insurance company. The Indian non-life insurance company, backed by Canada-based Fairfax Group, expects to raise INR 26.15 billion. The offering price range is expected to be INR 258-272 per share, with 41.36 million primary shares and 54.77 million secondary shares being offered. The stock is expected to trade on May 23, 2024. The managers of the offering are Axis Bank Ltd, Edelweiss Financial Services Ltd, HDFC Bank, ICICI, IIFL Finance Ltd, and Morgan Stanley.
Bowhead Specialty Holdings Inc (Ticker: BOW US) is a property and casualty insurance company that provides casualty and professional liability products. The company expects to raise $106.67 million by selling 6.67 million shares in the price range of $14-16, with pricing set for May 22, 2024. The offering is managed by JP Morgan Securities (Left Lead), Keefe Bruyette & Woods, and Morgan Stanley.
Sunho Biologics (Ticker: 2898 HK) is a Chinese biopharmaceutical company committed to the discovery, development, and commercialization of first-in-class/best-in-class biologics that regulate the immune microenvironment by directly modulating both the innate and adaptive immune systems. Leveraging a deep understanding of immunology, Sunho has developed various types of immunotherapies, including immunocytokines, to treat cancers and autoimmune diseases. The company will list on May 24, 2024, in Hong Kong. Sunho Biologics is offering 34.15 million primary shares at the price of HKD 13.50 per share, aiming to raise HKD 461.05 million (USD 58.94 million).
Astroscale Holdings Inc. (Ticker: 186A JP) is a Japanese space company that specializes in offering commercial services for the removal of space debris. Astroscale Holdings Inc. will list on June 5 on the Tokyo Stock Exchange’s Growth market. The company plans to sell between 23,593,300 and 26,718,200 shares at an indicative IPO price of 720 yen per share. The final IPO price is set to be determined on May 27. The estimated market capitalization at the time of listing is approximately 80.4 billion yen (USD equivalent not specified). The total offer size based on the indicative price will be calculated once the final share count and price are determined. The offering is managed by Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. Founder Mitsunobu Okada will offer 2.76 million shares in the IPO.
Past IPOs
Disclaimer
The IPOX Deal Calendar may not provide a complete list of all global initial public offerings (IPOs). Deals presented are subject to minimum market capitalization requirement and minimum deal size requirement. Informations about the companies may contain errors. Images are for illustrative purposes only. Companies pursing an IPO on Over-The-Counter (OTC) markets, best efforts offerings, closed-end fund (CEF), REITs, mainland China stock (A share) are not included. Please refer to the Legal Disclaimer.